TM is a 60-year-old male who presents for a clinic follow-up visit. Past medical history (PMH) includes MS (diagnosed in 2015), muscle spasms, hypertension, hyperlipidemia, urinary frequency, and chronic constipation. His current medications are dimethyl fumarate, baclofen, mirabegron, amlodipine, lisinopril, atorvastatin, and MiraLAX. He has tried fingolimod and glatiramer in the past. Dimethyl fumarate was initiated 5 years ago with no MRI changes or relapses since initiation; however, TM has had recurrent pneumonia infections over the past year. TM would like to know if it is reasonable to stop DMTs to prevent recurrent infections. Based on TM’s clinical history and results of the DISCOMS and DOT-MS trials, what would is the best recommendation for TM? A. Continue dimethyl fumarate, as TM should remain on a DMT indefinitely regardless of infection risk B. Discontinue dimethyl fumarate and monitor for MRI changes, as both clinical trials indicate that there is no increase in relapses if DMTs are discontinued C. Discontinue dimethyl fumarate and monitor for MRI changes, as the risk of recurrent infections outweighs the benefit of DMT continuation at this time D. Switch to a high-efficacy DMT due to the increase in relapses in the DMT discontinuation groups in both clinical trials
[Solved]: TM is a 60-year-old male who presents for a clinic…
Need help with your Cardiovascular Pharmacology case study or NCLEX preparation? Connect with a verified Nursing expert now.